APG Asset Management N.V. Has $16.37 Million Holdings in Mettler-Toledo International, Inc. $MTD

Key Points

• APG Asset Management N.V. reduced its stake in Mettler-Toledo International, Inc., holding approximately 14,973 shares valued at $16.37 million following a sale of 445 shares.
• Several analysts have set new price targets for Mettler-Toledo, with estimates ranging from $1,110 to $1,530, indicating varying levels of confidence in the stock.
• Mettler-Toledo reported a 3.9% increase in quarterly revenue year-over-year, with earnings surpassing analysts' expectations at $10.09 per share.

APG Asset Management N.V. lessened its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 2.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 14,973 shares of the medical instruments supplier's stock after selling 445 shares during the period. APG Asset Management N.V. owned about 0.07% of Mettler-Toledo International worth $16,369,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC boosted its position in shares of Mettler-Toledo International by 39.1% in the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock worth $103,000 after buying an additional 25 shares during the period. QRG Capital Management Inc. grew its holdings in Mettler-Toledo International by 29.4% during the 1st quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock valued at $577,000 after purchasing an additional 111 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in Mettler-Toledo International by 13.3% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier's stock valued at $2,929,000 after buying an additional 292 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Mettler-Toledo International by 95.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock worth $2,600,000 after acquiring an additional 1,073 shares in the last quarter. Finally, Boston Trust Walden Corp increased its holdings in Mettler-Toledo International by 7.1% during the 1st quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier's stock worth $40,871,000 after purchasing an additional 2,296 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the company's stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total value of $376,227.00. Following the transaction, the chief financial officer owned 5,095 shares in the company, valued at approximately $6,389,588.55. This represents a 5.56% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of the business's stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director owned 283 shares in the company, valued at approximately $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,827 shares of company stock valued at $2,371,208. Company insiders own 1.94% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Evercore ISI decreased their price objective on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a report on Monday, August 4th. Bank of America lifted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a report on Thursday, June 26th. Wells Fargo & Company boosted their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research report on Monday, May 5th. Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their target price for the company from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Finally, Robert W. Baird boosted their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, Mettler-Toledo International has an average rating of "Moderate Buy" and an average target price of $1,311.11.

Mettler-Toledo International Trading Down 0.1%

NYSE:MTD traded down $0.96 during mid-day trading on Thursday, reaching $1,284.28. 182,104 shares of the stock were exchanged, compared to its average volume of 172,876. The firm has a market capitalization of $26.46 billion, a PE ratio of 32.52, a PEG ratio of 3.85 and a beta of 1.34. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,521.01. The business has a fifty day moving average price of $1,235.26 and a 200 day moving average price of $1,187.41.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. During the same period in the previous year, the firm posted $9.65 EPS. The company's quarterly revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, sell-side analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.